(VRXA)
23.57
+0.00 (0.00%)
NASDAQ· Last Trade: Jun 11th, 3:36 PM EDT
Detailed Quote
| Previous Close | - |
|---|---|
| Open | 18.65 |
| Day's Range | 15.25 - 27.36 |
| 52 Week Range | N/A - N/A |
| Volume | 26,325 |
| Market Cap | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
BioMedNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Completes Business Combination and Begins Trading on Nasdaq
VERAXA Biotech (NASDAQ: VRXA) announced the successful closing of its previously announced business combination with Voyager Acquisition Corp. (NASDAQ: VACH), resulting in the formation of VERAXA Biotech AG, which will begin trading on the Nasdaq Capital Market under the ticker symbol VRXA, with warrants trading under VRXAW. The company is developing a pipeline of bispecific T-cell engagers and antibody-drug conjugates based on its proprietary BiTAC platform, which is designed to selectively target cancer cells while sparing healthy tissue.
Via Investor Brand Network · June 11, 2026
VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’
VERAXA Biotech has successfully concluded a business combination with Voyager Acquisition Corp. (NASDAQ: VACH) and began trading on the NASDAQ Capital Market under the ticker symbol ‘VRXA’ on June 11, 2026.
Via Investor Brand Network · June 11, 2026